Quoted from http://www.law.com/sites/articles/2015/10/15/third-risperdal-trial-in-philadelphia-begins/
Third Risperdal Trial in Philadelphia Begins
By P.J. D'Annunzio
Published: Oct 15, 2015
Lawyers in the third Risperdal gynecomastia trial against Johnson & Johnson subsidiary Janssen Pharmaceuticals in the Philadelphia Court of Common Pleas on Thursday painted starkly different pictures to the jury on what caused a young boy to grow enlarged breasts.
Plaintiff Tim Stange’s case will be the tiebreaker in the litigation, as the first and second trials resulted in victories for the plaintiff and defendants, respectively.
On Feb. 25, a jury awarded $2.5 million to plaintiff Austin Pledger, while on March 20, the jury in plaintiff William Cirba’s case came back in favor of Janssen.
Stange, like the other plaintiffs, alleged his use of the antipsychotic drug Risperdal caused him to develop enlarged breasts. Stange took Risperdal from 2006 to 2009 to control his Tourette syndrome symptoms.